Atlas Trials

Fecal Microbiota Transplant (FMT) Plus Fidaxomicin for Severe or Fulminant Clostridium Difficile Infection

Clinical trial NCT03760484 · TERMINATED

Trial details

NCT number
NCT03760484
Sponsor
University of Alberta
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Clostridium Difficile
Start date
2019-01-21
Primary completion
2020-03-10
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.